These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9799568)

  • 1. Isolation of partially purified P450 2D18 and characterization of activity toward the tricyclic antidepressants imipramine and desipramine.
    Thompson CM; Kawashima H; Strobel HW
    Arch Biochem Biophys; 1998 Nov; 359(1):115-21. PubMed ID: 9799568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant cytochrome P450 2D18 metabolism of dopamine and arachidonic acid.
    Thompson CM; Capdevila JH; Strobel HW
    J Pharmacol Exp Ther; 2000 Sep; 294(3):1120-30. PubMed ID: 10945868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition and metabolite complexation of rat hepatic microsomal cytochrome P450 by tricyclic antidepressants.
    Murray M; Field SL
    Biochem Pharmacol; 1992 May; 43(10):2065-71. PubMed ID: 1599495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of imipramine and three metabolites produced by isozyme CYP2D6 expressed in a human cell line.
    Su P; Coutts RT; Baker GB; Daneshtalab M
    Xenobiotica; 1993 Nov; 23(11):1289-98. PubMed ID: 8310712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of CYP3A9 gene expression by estrogen and catalytic studies using cytochrome P450 3A9 expressed in Escherichia coli.
    Wang H; Strobel HW
    Arch Biochem Biophys; 1997 Aug; 344(2):365-72. PubMed ID: 9264551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on cytochrome P450 responsible for oxidative metabolism of imipramine in human liver microsomes.
    Ohmori S; Takeda S; Rikihisa T; Kiuchi M; Kanakubo Y; Kitada M
    Biol Pharm Bull; 1993 Jun; 16(6):571-5. PubMed ID: 8364509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro metabolism of imipramine by brain microsomes: effects of inhibitors and exogenous cytochrome P450 reductase.
    Sequeira DJ; Strobel HW
    Brain Res; 1996 Oct; 738(1):24-31. PubMed ID: 8949923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of microsomal cytochromes P450 in rat liver by the tricyclic antidepressant drug desipramine and its primary oxidized metabolites.
    McNeil CM; Murray M
    Biochem Pharmacol; 1996 Jan; 51(1):15-20. PubMed ID: 8534263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of desipramine hydroxylation in vitro by serotonin-reuptake-inhibitor antidepressants, and by quinidine and ketoconazole: a model system to predict drug interactions in vivo.
    von Moltke LL; Greenblatt DJ; Cotreau-Bibbo MM; Duan SX; Harmatz JS; Shader RI
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1278-83. PubMed ID: 8138941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of ketoconazole on the pharmacokinetics of imipramine and desipramine in healthy subjects.
    Spina E; Avenoso A; Campo GM; Scordo MG; Caputi AP; Perucca E
    Br J Clin Pharmacol; 1997 Mar; 43(3):315-8. PubMed ID: 9088587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of cytochrome P450 3A1/2 as the major P450 isoform responsible for the metabolism of fentanyl by rat liver microsomes.
    Feierman DE
    Anesth Analg; 1996 May; 82(5):936-41. PubMed ID: 8610902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of catalytical activity and stereoselectivity between the recombinant human cytochrome P450 2D6.1 and 2D6.10.
    Kong LM; Qian MR; Hu HH; Xu SY; Yu LS; Jiang HD; Chen SQ; Zeng S
    Pharmazie; 2012 May; 67(5):440-7. PubMed ID: 22764579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and characterization of canine cytochrome P450 2D15.
    Roussel F; Duignan DB; Lawton MP; Obach RS; Strick CA; Tweedie DJ
    Arch Biochem Biophys; 1998 Sep; 357(1):27-36. PubMed ID: 9721180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions of two major metabolites of prasugrel, a thienopyridine antiplatelet agent, with the cytochromes P450.
    Rehmel JL; Eckstein JA; Farid NA; Heim JB; Kasper SC; Kurihara A; Wrighton SA; Ring BJ
    Drug Metab Dispos; 2006 Apr; 34(4):600-7. PubMed ID: 16415119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interactions of a selective protein kinase C beta inhibitor with the human cytochromes P450.
    Ring BJ; Gillespie JS; Binkley SN; Campanale KM; Wrighton SA
    Drug Metab Dispos; 2002 Sep; 30(9):957-61. PubMed ID: 12167559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of human liver cytochrome P450 enzymes that metabolize the nonsedating antihistamine loratadine. Formation of descarboethoxyloratadine by CYP3A4 and CYP2D6.
    Yumibe N; Huie K; Chen KJ; Snow M; Clement RP; Cayen MN
    Biochem Pharmacol; 1996 Jan; 51(2):165-72. PubMed ID: 8615885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidation of 1,8-cineole, the monoterpene cyclic ether originated from eucalyptus polybractea, by cytochrome P450 3A enzymes in rat and human liver microsomes.
    Miyazawa M; Shindo M; Shimada T
    Drug Metab Dispos; 2001 Feb; 29(2):200-5. PubMed ID: 11159812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism of endosulfan-alpha by human liver microsomes and its utility as a simultaneous in vitro probe for CYP2B6 and CYP3A4.
    Casabar RC; Wallace AD; Hodgson E; Rose RL
    Drug Metab Dispos; 2006 Oct; 34(10):1779-85. PubMed ID: 16855053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition and kinetics of cytochrome P4503A activity in microsomes from rat, human, and cdna-expressed human cytochrome P450.
    Ghosal A; Satoh H; Thomas PE; Bush E; Moore D
    Drug Metab Dispos; 1996 Sep; 24(9):940-7. PubMed ID: 8886602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequential metabolism of secondary alkyl amines to metabolic-intermediate complexes: opposing roles for the secondary hydroxylamine and primary amine metabolites of desipramine, (s)-fluoxetine, and N-desmethyldiltiazem.
    Hanson KL; VandenBrink BM; Babu KN; Allen KE; Nelson WL; Kunze KL
    Drug Metab Dispos; 2010 Jun; 38(6):963-72. PubMed ID: 20200233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.